Clinical Trials Directory

Trials / Unknown

UnknownNCT01694459

DEDICA (Dose of HEparin During Coronary Angioplasty) Trial

Comparison of Low-dose Heparin Versus Standard Dose Heparin During Coronary Interventions (DEDICA Trial)

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
1,000 (estimated)
Sponsor
San Filippo Neri General Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

International guidelines support the use of a full-dose heparin (anticoagulants) during coronary intervention. However, a lower dose of heparin may be adequate, thanks to advances in angioplasty techniques and the widespread use of pretreatment with two antiplatelet agents. Thus the investigators designed a study comparing safety and efficacy of standard dose heparin (100 UI/Kg) versus low-dose (50 UI/Kg) in patients undergoing coronary angioplasty who are on aspirin and clopidogrel at the time of the procedure.

Detailed description

* Patients undergoing coronary angioplasty will be randomised to standard vs. low-dose heparin. the study will include "all-comers" (patients with either stable angina or acute coronary syndromes); only patients with ST-elevation myocardial infarction will be excluded. * An ACT (activated clotting time) will be performed after the initial bolus of heparin: for the standard dose group the target ACT will be \> 300 sec. (as recommended by guidelines) while for the low-dose the target ACT will be \> 180 sec. Aim of the study is to show equivalence in ischemic events between the two doses of heparin, in order to confirm the safety of lower dose of heparin in contemporary coronary interventions.

Conditions

Interventions

TypeNameDescription
DRUGLow-dose heparinBolus of 50 UI/Kg of heparin at the beginning of coronary interventions
DRUGStandard dose heparinBolus of 100 UI/Kg of heparin at the beginning of coronary interventional procedure.

Timeline

Start date
2010-01-01
Primary completion
2012-12-01
Completion
2012-12-01
First posted
2012-09-27
Last updated
2012-09-27

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT01694459. Inclusion in this directory is not an endorsement.